【摘要】 目的 探討益生菌治療在潰瘍性結(jié)腸炎(ulcerative colitis,UC)患者中的臨床應(yīng)用效果。 方法 選取2007年8月-2009年12月47例活動(dòng)期UC患者,隨機(jī)分為治療組和對(duì)照組,分別給予益生菌和5-氨基水楊酸治療,療程8周。監(jiān)測(cè)治療期間患者的臨床癥狀和血清C反應(yīng)蛋白(Creactive protein,CRP)水平。 結(jié)果 治療結(jié)束后兩組患者臨床癥狀均有緩解,CRP水平均明顯下降,兩組間無統(tǒng)計(jì)學(xué)意義(P gt;0.05)。 結(jié)論 益生菌治療UC可有效改善患者臨床癥狀和炎癥反應(yīng)。
引用本文: 張淑平,代嘉莉,代加平. 益生菌治療在潰瘍性結(jié)腸炎中的臨床應(yīng)用. 華西醫(yī)學(xué), 2010, 25(9): 1713-1714. doi: 復(fù)制
版權(quán)信息: ?四川大學(xué)華西醫(yī)院華西期刊社《華西醫(yī)學(xué)》版權(quán)所有,未經(jīng)授權(quán)不得轉(zhuǎn)載、改編
1. | Kruis W, Fric P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic escherichia coli nissle 1917 is as effective as with standard mesalazine [J]. Gut, 2004, 53(11): 1617-1623. |
2. | 中華醫(yī)學(xué)會(huì)消化病學(xué)分會(huì)炎癥性腸病協(xié)作組. 對(duì)我國(guó)炎癥性腸病診斷治療規(guī)范的共識(shí)意見[J]. 中華消化雜志, 2007, 27(8): 545-550. |
3. | Masseret E, Boudeau J, Colombel JF, et al. Genetically related Escherichia coli strains associated with Crohn′s disease [J]. Gut, 2001, 48(3): 320-325. |
4. | Fabia R, Ar′Rajab A, Johansson ML, et al. Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat [J]. Digestion, 1993, 54(4): 248-255. |
5. | Laudanno OM, Cesolari JA, Godoy A, et al. Bioflora probiotic in immunomodulation and prophylaxis of intestinal bacterial translocation in rats[J]. Dig Dis Sci, 2008, 53(10): 2667-2670. |
6. | Schiffrin EJ, Blum S. Interactions between the microbiota and the intestinal mucosa [J]. Eur J Clin Nutr, 2002, 56(Suppl 3): 60-64. |
- 1. Kruis W, Fric P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic escherichia coli nissle 1917 is as effective as with standard mesalazine [J]. Gut, 2004, 53(11): 1617-1623.
- 2. 中華醫(yī)學(xué)會(huì)消化病學(xué)分會(huì)炎癥性腸病協(xié)作組. 對(duì)我國(guó)炎癥性腸病診斷治療規(guī)范的共識(shí)意見[J]. 中華消化雜志, 2007, 27(8): 545-550.
- 3. Masseret E, Boudeau J, Colombel JF, et al. Genetically related Escherichia coli strains associated with Crohn′s disease [J]. Gut, 2001, 48(3): 320-325.
- 4. Fabia R, Ar′Rajab A, Johansson ML, et al. Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat [J]. Digestion, 1993, 54(4): 248-255.
- 5. Laudanno OM, Cesolari JA, Godoy A, et al. Bioflora probiotic in immunomodulation and prophylaxis of intestinal bacterial translocation in rats[J]. Dig Dis Sci, 2008, 53(10): 2667-2670.
- 6. Schiffrin EJ, Blum S. Interactions between the microbiota and the intestinal mucosa [J]. Eur J Clin Nutr, 2002, 56(Suppl 3): 60-64.